Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126291253 | 12629125 | 3 | F | 20160924 | 20160808 | 20160928 | EXP | US-AMGEN-USASP2016100452 | AMGEN | 0.00 | F | Y | 0.00000 | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126291253 | 12629125 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | UNK UNK, UNK | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 126291253 | 12629125 | 2 | SS | NPLATE | ROMIPLOSTIM | 1 | Unknown | UNK | U | 0 | POWDER FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126291253 | 12629125 | 1 | Product used for unknown indication |
| 126291253 | 12629125 | 2 | Myelodysplastic syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126291253 | 12629125 | HO |
| 126291253 | 12629125 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126291253 | 12629125 | Cerebral haemorrhage | |
| 126291253 | 12629125 | Fatigue | |
| 126291253 | 12629125 | Malaise | |
| 126291253 | 12629125 | Nausea | |
| 126291253 | 12629125 | Off label use | |
| 126291253 | 12629125 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |